
Feds buy another $1.29B worth of Lilly antibody treatment for COVID-19
The purchase will amount to 614,000 doses of two drugs, bamlanivimab and etesevimab, that make up the drug-cocktail infusion, Lilly said.
The purchase will amount to 614,000 doses of two drugs, bamlanivimab and etesevimab, that make up the drug-cocktail infusion, Lilly said.
Anticipating a green light from vaccine advisers, the Biden administration is assembling and shipping millions of COVID-19 shots for children ages 5-11, the White House said Monday. The first could go into arms by midweek.
Statewide hospitalizations due to COVID-19 ticked up from 1,284 on Saturday to 1,297 on Sunday. Saturday’s number was the lowest since Aug. 8.
U.S. regulators are delaying their decision on Moderna’s COVID-19 vaccine for 12- to 17-year-olds while they study the rare risk of heart inflammation, the company said Sunday.
Breakthrough cases of COVID-19—when a fully vaccinated person tests positive for the virus—make up a low ratio of COVID cases in Indiana, but they aren’t extremely rare.
Indiana officials said Wednesday that the state should be able to immediately inoculate a third of children ages 5 to 11 if the federal government gives approval to vaccines for that age group.
Researchers tested the pill used for depression and obsessive-compulsive disorder because it was known to reduce inflammation and looked promising in smaller studies.
The cumulative total of deaths during the pandemic officially rose to 16,022, the department said Tuesday. Another 545 probable deaths due to COVID also have been reported.
An influential COVID-19 forecasting model is predicting increasing infections and hospitalizations in November. Also, COVID deaths per day have begun to creep back up again after a decline that started in late September.
Statewide hospitalizations due to COVID-19 have dropped 32% since the beginning of the month and 51% since hitting a recent peak of 2,687 on Sept. 13.
Gov. Eric Holcomb is asking the state’s high court to review a judge’s ruling that upheld a new law giving legislators more power to intervene during public health emergencies.
Details of Pfizer’s study were posted online. The Food and Drug Administration was expected to post its independent review of the company’s safety and effectiveness data later in the day on Friday.
About two-thirds of Americans eligible for COVID-19 shots are fully vaccinated, and the government says getting first shots to the unvaccinated remains the priority.
Statewide hospitalizations due to COVID-19 decreased from 1,475 on Tuesday to 1,445 on Wednesday, their lowest number since Aug. 13.
Some conservative Indiana lawmakers who want to stymie planned COVID-19 vaccine mandates for private employers are facing skepticism from their own Republican leaders and the state’s largest business group.
More than 247,000 Hoosiers have already gotten vaccine boosters, after a daily increase of 5,690.
Federal regulators will meet over the next two weeks to weigh the benefits of giving shots to children, after lengthy studies meant to ensure the safety of the vaccines.
Statewide hospitalizations due to COVID-19 decreased from 1,576 on Sunday to 1,551 on Monday, their lowest number since Aug. 16.
Preliminary results of a U.S. government-sponsored trial found that mixing coronavirus vaccines produces as much or more antibodies as using the same shot as a booster.
More than a year and a half after the coronavirus pandemic upended daily life, the supply of basic goods at U.S. grocery stores and restaurants is once again falling victim to intermittent shortages and delays.